Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-08

Clinical Trial Update: Effect of Allopurinol Administration on the Prevention of Muscle Mass Loss in Subject Immobilized. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated whether allopurinol administration can prevent skeletal muscle mass loss in immobilized patients with a Grade II ankle sprain…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: Instituto de Investigacion Sanitaria La Fe | Conditions: Patients With Grade II Ankle Sprain | Phase 3 | Status: COMPLETED